Stephen J. Tulipano is CFO at Stoke Therapeutics, Inc. (STOK). They have made 5 open-market trades across 3 companies since 2010, most recently 2024-03-19.
CIK 0001360548
1 open-market purchase totalling $15K since 2017, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| STOK | SELL | 2024-03-19 | 2024-03-19 | $6.10 | $25K | +131.8% | +100.2% | +168.0% |
| STOK | SELL | 2021-02-22 | 2021-02-24 | $58.89 | $3.2M | -15.6% | -36.8% | -37.2% |
| STOK | SELL | 2020-11-02 | 2020-11-04 | $39.00 | $5.4M | +12.8% | +23.2% | +57.4% |
| ALDX | BUY | 2017-02-17 | 2017-02-21 | $4.50 | $15K | +1.0% | -2.1% | -13.9% |
| JAV | SELL | 2010-05-03 | 2010-05-05 | $2.18 | $5K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.